공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 암 생검 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2019-2026년)

Global Cancer Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

리서치사 Value Market Research
발행일 2021년 01월 상품 코드 980924
페이지 정보 영문 169 Pages
가격
US $ 2,100 ₩ 2,373,000 Data Pack (Single User License)
US $ 3,950 ₩ 4,464,000 PDF (Single User License)
US $ 4,950 ₩ 5,594,000 PDF (10-user License)
US $ 8,600 ₩ 9,720,000 PDF (Corporate User License)


세계의 암 생검 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2019-2026년) Global Cancer Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
발행일 : 2021년 01월 페이지 정보 : 영문 169 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암 생검(Cancer Biopsy) 시장에 대해 조사했으며, 시장 기회와 동향, 성장 촉진요인 및 억제요인, COVID-19 팬데믹의 영향, 제품·종류·용도·지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서문

제2장 개요

제3장 업계 분석

  • 시장 역학
  • 시장 성장요인
  • 시장 억제요인
  • 시장 기회
  • 업계 동향
  • Porter의 산업 분석
  • 시장의 매력 분석

제4장 밸류체인 분석

  • 밸류체인 분석
  • 원재료 분석
  • 잠재적인 바이어 리스트
  • 마케팅 채널

제5장 COVID-19 발생의 영향 분석

  • COVID-19 발생의 영향 분석
  • 생산량 : 수입/수출/수요별 영향 분석
  • 시장 : COVID-19 이전/이후
  • COVID-19 팬데믹의 추정되는 영향
  • COVID-19 : 미시적/거시적 요인 분석

제6장 시장 분석 : 제품별

  • 개요
  • 과거/예측 데이터
  • 제품별 분석
  • 기기
  • 키트 및 소모품
  • 서비스

제7장 시장 분석 : 유형별

  • 개요
  • 과거/예측 데이터
  • 유형별 분석
  • 조직 생검(침 생검, 세침검사(FNA), 중심바늘생검(CNB), 외과 생검)
  • 액체생검
  • 기타

제8장 시장 분석 : 용도별

  • 개요
  • 과거/예측 데이터
  • 용도별 분석
  • 유방암 시장
  • 결장직장암
  • 자궁경부암
  • 폐암
  • 전립선암
  • 피부암
  • 혈액암
  • 신장암
  • 간암
  • 췌장암
  • 난소암

제9장 시장 분석 : 지역별

  • 지역 전망
  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 구도

  • 시장 경쟁
  • 제휴/협업/계약
  • 인수합병(M&A)
  • 신제품 발매
  • 기타 개발

제11장 기업 개요

  • 기업 점유율 분석
  • 시장 집중률
  • Qiagen NV
  • GRAIL, Inc
  • Illumina, Inc.
  • ANGLE Plc
  • BD(Becton, Dickinson And Company)
  • Myriad Genetics
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Lucence Diagnostics Pte. Ltd.
  • Guardant Health
  • Exact Sciences Corporation
  • Biodesix(Integrated Diagnostics)
  • Freenome Holdings, Inc.
LSH 21.01.20

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Instruments Market by Geography (USD MN)
  • Kits and Consumables Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
  • Liquid Biopsies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Colorectal Cancer Market by Geography (USD MN)
  • Cervical Cancers Market by Geography (USD MN)
  • Lung Cancers Market by Geography (USD MN)
  • Prostate Cancers Market by Geography (USD MN)
  • Skin Cancers Market by Geography (USD MN)
  • Blood Cancers Market by Geography (USD MN)
  • Kidney Cancers Market by Geography (USD MN)
  • Liver Cancers Market by Geography (USD MN)
  • Pancreatic Cancers Market by Geography (USD MN)
  • Ovarian Cancers Market by Geography (USD MN)
  • Global Cancer Biopsy Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cancer Biopsy Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Biopsy Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Instruments Market by Geography (USD MN)
  • Kits and Consumables Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
  • Liquid Biopsies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Colorectal Cancer Market by Geography (USD MN)
  • Cervical Cancers Market by Geography (USD MN)
  • Lung Cancers Market by Geography (USD MN)
  • Prostate Cancers Market by Geography (USD MN)
  • Skin Cancers Market by Geography (USD MN)
  • Blood Cancers Market by Geography (USD MN)
  • Kidney Cancers Market by Geography (USD MN)
  • Liver Cancers Market by Geography (USD MN)
  • Pancreatic Cancers Market by Geography (USD MN)
  • Ovarian Cancers Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2019

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Value Market Research's latest report on the Global Cancer Biopsy Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global cancer biopsy market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global cancer biopsy market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global cancer biopsy market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global cancer biopsy market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global cancer biopsy market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global cancer biopsy market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global cancer biopsy market.

The market analysis involves a section exclusively to list the major players of the global cancer biopsy market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Cancer Biopsy Market Report Segments the market as below:

By Product

  • Instruments
  • Kits and Consumables
  • Services

By Type

  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies)
  • Liquid Biopsies
  • Others

By Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Liver Cancers
  • Pancreatic Cancers
  • Ovarian Cancers
  • Others

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CANCER BIOPSY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product
    • 3.7.2 By Type
    • 3.7.3 By Application
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Instruments Market by Regions
  • 6.6 Kits and Consumables Market by Regions
  • 6.5 Services Market by Regions

7 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Regions
  • 7.5 Liquid Biopsies Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Breast Cancer Market by Regions
  • 8.5 Colorectal Cancer Market by Regions
  • 8.6 Cervical Cancers Market by Regions
  • 8.7 Lung Cancers Market by Regions
  • 8.8 Prostate Cancers Market by Regions
  • 8.9 Skin Cancers Market by Regions
  • 8.10. Blood Cancers Market by Regions
  • 8.11 Kidney Cancers Market by Regions
  • 8.12 Liver Cancers Market by Regions
  • 8.13 Pancreatic Cancers Market by Regions
  • 8.14 Ovarian Cancers Market by Regions

9 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE CANCER BIOPSY COMPANIES

  • 10.1. Cancer Biopsy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CANCER BIOPSY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Qiagen N.V.
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. GRAIL, Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Illumina, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. ANGLE Plc
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. BD (Becton, Dickinson And Company)
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Myriad Genetics
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Hologic, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Biocept, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Thermo Fisher Scientific, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Danaher
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. F. Hoffmann-La Roche Ltd.
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Lucence Diagnostics Pte. Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financials
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Guardant Health
    • 11.15.1. Company Overview
    • 11.15.2. Financials
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Exact Sciences Corporation
    • 11.16.1. Company Overview
    • 11.16.2. Financials
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Biodesix (Integrated Diagnostics)
    • 11.17.1. Company Overview
    • 11.17.2. Financials
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Freenome Holdings, Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financials
    • 11.18.3. Products
    • 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

Back to Top
전화 문의
F A Q